Merck KGaA

Microsoft’s Business Intelligence Solutions Resonate with Enterprises

As the second annual Microsoft Business Intelligence Conference opens, Microsoft BI tools empower information workers and drive performance at pharmaceutical leader Merck Co., Inc., highlighting market momentum. SEATTLE.—...

Arena Pharmaceuticals to Present at the Natixis Bleichroeder Second Annual Hidden Gems Conference

SAN DIEGO, Oct 07, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today that the company is scheduled to present at the Natixis Bleichroeder Second Annual Hidden Gems...

Study suggests LF elimination program is 'best buy in public health'

A study concludes that in the ten years since its initiation, the international effort to eliminate lymphatic filariasis has made a large impact towards eradication of the disease. These efforts are the result of the most rapid...

Merck Serono: Severe Adverse Event Reported in Raptiva Patient

Merck KGaA, together with its Merck Serono division, announced that Genentech Inc. has reported a case of progressive multifocal leukoencephalopathy (PML) in a 70-year old patient who had received ...

Merck & Co., Inc. Awards Five Grants to Humanitarian Aid Partners

WHITEHOUSE STATION, N.J., Oct. 2, 2008 - Merck & Co., Inc., today announced that it has awarded five grants totaling $250,000 to AmeriCares, Catholic Medical Mission Board (CMMB), Direct Relief International, IMA World Health...

SUPERVALU(R) Announces Sponsorship of American Heart Association's Go Red for Women

SUPERVALU INC.(R) (NYSE: SVU), one of the largest companies in the U.S. grocery channel whose nationwide family of stores includes ACME(R), ALBERTSONS(R), bigg's(R), CUB FOODS(R), FARM FRESH(R), HORNBACHER'S(R), JEWEL-OSCO(R),...

ARIAD Announces Favorable Ruling Permitting Immediate Appeal of District Court Findings on...

CAMBRIDGE, Mass.----ARIAD Pharmaceuticals, Inc. today announced that the U.S. District Court for the District of Delaware granted ARIAD's motion to permit an immediate appeal of the Court's summary judgment ruling of...

Merck Discontinues Development Of Investigational Medicine Taranabant For Obesity

Merck & Co., Inc. will not seek regulatory approval for taranabant, an investigational medicine, to treat obesity and is discontinuing its Phase III clinical development program for taranabant for obesity. "Available Phase III...

Drugmakers in the Dow fall with the overall market (AP)

Shares of drugmaker Pfizer Inc. hit their lowest level in more than a decade Monday as U.S. and global stock markets were in freefall amid widening fears over whether financial bailouts can unfreeze credit markets and stabilize...

Apollo, Merck unit to set up 200 diabetes clinics in India

Leading Indian healthcare group Apollo Hospitals (BSE:508869) Saturday entered into an agreement with the Indian arm of US-based drug maker Merck & Co to jointly set up 200 exclusive clinics to treat diabetes in India.